Prediction of short survival in patients with brain metastases based on three different scores: a role for 'triple-negative' status?

PubWeight™: 1.00‹?› | Rank: Top 15%

🔗 View Article (PMID 19762219)

Published in Clin Oncol (R Coll Radiol) on September 16, 2009

Authors

C Nieder1, A Pawinski, M Molls

Author Affiliations

1: Radiation Oncology Unit, Nordland Hospital, Bodø, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Tromsø, Tromsø, Norway. carsten.nieder@nlsh.no

Articles citing this

Diagnosis-specific graded prognostic assessment score is valid in patients with brain metastases treated in routine clinical practice in two European countries. Med Sci Monit (2012) 0.90

Best supportive care in patients with brain metastases and adverse prognostic factors: development of improved decision aids. Support Care Cancer (2013) 0.87

Defining treatment for brain metastases patients: nihilism versus optimism. Support Care Cancer (2011) 0.81

Surgical resection of brain metastases: the prognostic value of the graded prognostic assessment score. J Neurooncol (2011) 0.78

Palliative whole-brain radiotherapy and health- related quality of life for patients with brain metastasis in cancer. Neuropsychiatr Dis Treat (2015) 0.78

Towards improved prognostic scores predicting survival in patients with brain metastases: a pilot study of serum lactate dehydrogenase levels. ScientificWorldJournal (2012) 0.77

Analysis of prognostic factors and comparison of prognostic index scores in patients with brain metastases after whole-brain radiotherapy. Int J Clin Exp Med (2014) 0.76

Does Time between Imaging Diagnosis and Initiation of Radiotherapy Impact Survival after Whole-Brain Radiotherapy for Brain Metastases? ISRN Oncol (2013) 0.75

Cerebral metastasis from a previously undiagnosed appendiceal adenocarcinoma. Case Rep Oncol Med (2012) 0.75

Short Survival Time after Palliative whole Brain Radiotherapy: Can We Predict Potential Overtreatment by Use of a Nomogram? J Cancer (2017) 0.75

Articles by these authors

(truncated to the top 100)

Informatics and medicine--from molecules to populations. Methods Inf Med (2008) 2.13

High dose epirubicin is effective in measurable metastatic prostate cancer: a phase II study of the EORTC Genitourinary Group. Eur J Cancer (1995) 2.10

Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients. Br J Cancer (1997) 1.54

Influence of the hypoxic subvolume on the survival of patients with head and neck cancer. Int J Radiat Oncol Biol Phys (1999) 1.51

O-(2-[18F]fluoroethyl)-L-tyrosine and L-[methyl-11C]methionine uptake in brain tumours: initial results of a comparative study. Eur J Nucl Med (2000) 1.48

Neoadjuvant continuous infusion of weekly 5-fluorouracil and escalating doses of oxaliplatin plus concurrent radiation in locally advanced oesophageal squamous cell carcinoma: results of a phase I/II trial. Br J Cancer (2008) 1.42

A comparison of treatment results for recurrent malignant gliomas. Cancer Treat Rev (2000) 1.42

Fatigue, serum cytokine levels, and blood cell counts during radiotherapy of patients with breast cancer. Int J Radiat Oncol Biol Phys (2001) 1.38

Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys (2000) 1.17

Vascular endothelial growth factor measured in platelet poor plasma allows optimal separation between cancer patients and volunteers: a key to study an angiogenic marker in vivo? Ann Oncol (1999) 1.13

Combined preoperative chemotherapy and radiotherapy in patients with locally advanced esophageal cancer. Interim analysis of a phase II trial. J Clin Oncol (1996) 1.09

Responders benefit from neoadjuvant radiochemotherapy in esophageal squamous cell carcinoma: results of a prospective phase-II trial. Eur J Surg Oncol (2004) 1.06

Tumor hypoxia, p53, and prognosis in cervical cancers. Int J Radiat Oncol Biol Phys (2001) 1.04

Gastric Cancer. Curr Probl Surg (1997) 1.00

Rapid detection of radiation-induced chromosomal aberrations in lymphocytes and hematopoietic progenitor cells by mFISH. Mutat Res (2000) 1.00

Predictive value of the tumor oxygenation by means of pO2 histography in patients with advanced head and neck cancer. Strahlenther Onkol (2001) 0.99

Histopathological response after preoperative radiochemotherapy in rectal carcinoma is associated with improved overall survival. J Surg Oncol (2008) 0.97

Radiotherapy with or without chemotherapy in the treatment of anal cancer: 20-year experience from a single institute. Strahlenther Onkol (2012) 0.97

Advanced techniques in neoadjuvant radiotherapy allow dose escalation without increased dose to the organs at risk : Planning study in esophageal carcinoma. Strahlenther Onkol (2013) 0.96

Squamous cell carcinoma and Zenker diverticulum. Dis Esophagus (2007) 0.93

Ten-year data on 138 patients with endometrial carcinoma and postoperative vaginal brachytherapy alone: no need for external-beam radiotherapy in low and intermediate risk patients. Gynecol Oncol (2007) 0.92

No evidence for a different RBE between pulsed and continuous 20 MeV protons. Radiat Res (2009) 0.91

Salvage radiotherapy in patients with recurrent esophageal carcinoma. Strahlenther Onkol (2012) 0.90

The effectiveness of 20 mev protons at nanosecond pulse lengths in producing chromosome aberrations in human-hamster hybrid cells. Radiat Res (2011) 0.90

Prediction of very short survival in patients with brain metastases from breast cancer. Clin Oncol (R Coll Radiol) (2008) 0.88

From heart to heart for breast cancer patients - cardiovascular toxicities in breast cancer radiotherapy. Strahlenther Onkol (2013) 0.88

Three-dimensional imaging of whole mouse models: comparing nondestructive X-ray phase-contrast micro-CT with cryotome-based planar epi-illumination imaging. J Microsc (2013) 0.87

Blood flow and oxygenation status of human tumors. Clinical investigations. Strahlenther Onkol (1999) 0.87

Radiation response in 10 high-grade human soft tissue sarcoma xenografts to photons and fast neutrons. Int J Radiat Oncol Biol Phys (1990) 0.86

Oxygen-induced MR signal changes in murine tumors. Magn Reson Imaging (1998) 0.86

Prospective flow cytometric analysis of head and neck carcinomas. Prognostic relevance of DNA-content and S-fraction. J Craniomaxillofac Surg (1992) 0.85

Influence of differing radiotherapy strategies on treatment results in diffuse large-cell lymphoma: a review. Cancer Treat Rev (2003) 0.85

Changes in tumor oxygenation during combined treatment with split-course radiotherapy and chemotherapy in patients with head and neck cancer. Radiother Oncol (1998) 0.85

Tumor hypoxia and systemic levels of vascular endothelial growth factor (VEGF) in head and neck cancers. Strahlenther Onkol (2001) 0.85

Respiratory gated [18F]FDG PET/CT for target volume delineation in stereotactic radiation treatment of liver metastases. Strahlenther Onkol (2012) 0.85

Low LET protons focused to submicrometer shows enhanced radiobiological effectiveness. Phys Med Biol (2012) 0.84

Radio(chemo)therapy in the management of squamous cell carcinoma of cervical lymph nodes from an unknown primary site. A retrospective analysis. Strahlenther Onkol (2011) 0.83

Phase II trial of vinorelbine in patients with advanced and/or recurrent cervical carcinoma: an EORTC Gynaecological Cancer Cooperative Group Study. Eur J Cancer (2000) 0.83

Limited resection and free jejunal graft interposition for squamous cell carcinoma of the cervical oesophagus. Br J Surg (2009) 0.83

Lung effects after total body irradiation of mice and bone marrow transplant patients: comparison of experimental and preliminary clinical data. Recent Results Cancer Res (1993) 0.82

Fractionated stereotactic radiotherapy in the treatment of pituitary adenomas. Strahlenther Onkol (2013) 0.82

Computer analysis of mFISH chromosome aberration data uncovers an excess of very complicated metaphases. Int J Radiat Biol (2002) 0.82

The value of F-18-fluorodeoxyglucose PET for the 3-D radiation treatment planning of malignant gliomas. Int J Radiat Oncol Biol Phys (1998) 0.82

Kinetics of cell proliferation in the pre-implanted mouse embryo in vivo and in vitro. Cell Tissue Kinet (1980) 0.82

Positron-emission tomography CT to identify local recurrence in stage I lung cancer patients 1 year after stereotactic body radiation therapy. Strahlenther Onkol (2013) 0.81

Follow-up analysis of translocation and dicentric frequencies, measured by FISH-chromosome painting in breast cancer patients after partial-body radiotherapy with little bone marrow exposure. Mutat Res (1999) 0.80

Changes in head and neck tumor hypoxic fraction during split-course radiochemotherapy. Ann Otol Rhinol Laryngol (1999) 0.80

Protection of quality and innovation in radiation oncology: the prospective multicenter trial QUIRO of DEGRO: evaluation of time, attendance of medical staff, and resources during radiotherapy with tomotherapy. Strahlenther Onkol (2014) 0.80

The EORTC Phase II study of iproplatin in advanced osteogenic sarcoma. Eur J Cancer (1999) 0.80

[The flab method of intraoperative radiotherapy]. Strahlenther Onkol (1995) 0.80

Dose-escalated simultaneous integrated-boost treatment of prostate cancer patients via helical tomotherapy. Strahlenther Onkol (2012) 0.80

Fluorine-18-FDG PET and iodine-123-IMT SPECT in the evaluation of brain tumors. J Nucl Med (1997) 0.80

Induction and repair of DNA double-strand breaks assessed by gamma-H2AX foci after irradiation with pulsed or continuous proton beams. Radiat Environ Biophys (2012) 0.79

Imaging of tumor physiology: impacts on clinical radiation oncology. Exp Oncol (2010) 0.79

Chronic adverse events and quality of life after radiochemotherapy in anal cancer patients. A single institution experience and review of the literature. Strahlenther Onkol (2013) 0.79

First experience with I-123-alpha-methyl-tyrosine spect in the 3-D radiation treatment planning of brain gliomas. Int J Radiat Oncol Biol Phys (2000) 0.79

Locally advanced rectal cancer: resection and intraoperative radiotherapy using the flab method combined with preoperative or postoperative radiochemotherapy. Dis Colon Rectum (1996) 0.79

A comparison of the cell kinetics of pre-implantation mouse embryos from two different mouse strains. Cell Tissue Kinet (1983) 0.79

Cisplatin- vs. oxaliplatin-based radiosensitizing chemotherapy for squamous cell carcinoma of the esophagus: a comparison of two preoperative radiochemotherapy regimens. Strahlenther Onkol (2014) 0.79

Basal HIF-1α expression levels are not predictive for radiosensitivity of human cancer cell lines. Strahlenther Onkol (2012) 0.79

Oxygen tensions in rodent tumors after irradiation with neutrons. Adv Exp Med Biol (1997) 0.78

Radiation induced stress proteins. Int J Clin Pharmacol Ther (2010) 0.78

[Prostatic carcinoma: problems in the interpretation of rectal dose-volume histograms]. Strahlenther Onkol (2000) 0.78

Perspectives in the treatment of malignant gliomas in adults. Anticancer Res (2002) 0.78

Hyperthermia--its actual role in radiation oncology. Part III: Clinical rationale and results in deep seated tumors. Strahlenther Onkol (1995) 0.77

Clinical evidence for correlation of insufficient tissue oxygen supply (hypoxia) and tumor-associated proteolysis in squamous cell carcinoma of the head and neck. Int J Biol Markers (2001) 0.77

Evaluation of tumor blood perfusion by dynamic MRI and CT in patients undergoing thermoradiotherapy. Eur J Radiol (1993) 0.77

Combined radiochemotherapy with docetaxel in patients with unresectable locally advanced head and neck tumors. Strahlenther Onkol (2000) 0.77

Radioresponsiveness of a human soft tissue sarcoma xenograft to different single and fractionated regimens. Strahlenther Onkol (1989) 0.77

Radiotoxicities of [3H]thymidine and of [3H]arginine compared in mouse embryos in vitro. Radiat Res (1987) 0.77

The effects of lead and X-rays, alone or in combination, on blastocyst formation and cell kinetics of preimplantation mouse embryos in vitro. Int J Radiat Biol Relat Stud Phys Chem Med (1983) 0.77

Palliative radiotherapy of malignant melanoma with reactor fission neutron therapy (RENT): a prospective study. Radiat Oncol Investig (1999) 0.77

Radiotherapy in stage I-III follicular non-Hodgkin lymphoma. Retrospective analysis of a series of 50 patients. Strahlenther Onkol (2012) 0.77

The incidence of interstitial pneumonitis: comparison of total body irradiation schedules for allogenic bone marrow transplantation. Strahlenther Onkol (1986) 0.77

[Association between elevated serum VEGF and polarographically measured tumor hypoxia in head and neck carcinomas]. Strahlenther Onkol (2001) 0.77

Correlation between postoperative 3-[(123)I]iodo-L-alpha-methyltyrosine uptake and survival in patients with gliomas. J Nucl Med (2001) 0.76

The combination of hyperthermia and radiation: clinical investigations. Recent Results Cancer Res (1987) 0.76

Risk-related adjuvant chemotherapy for stage I non-seminoma of the testis. Clin Oncol (R Coll Radiol) (1991) 0.76

[No association between p53 overexpression and polarographically measured tumor oxygenation in patients with head and neck carcinomas]. Strahlenther Onkol (2000) 0.76

Intercellular adhesion molecule-1: a consistent inflammatory marker of the cutaneous radiation reaction both in vitro and in vivo. Br J Dermatol (2006) 0.76

A new class of drugs for BNCT? Borylated derivatives of ferrocenium compounds in animal experiments. Biometals (2001) 0.76

Changes in oxygenation patterns of locally advanced recurrent tumors under thermoradiotherapy. Adv Exp Med Biol (1994) 0.76

Oxygen tension in transplanted mouse osteosarcomas during fractionated high-LET- and low-LET radiotherapy--predictive aspects for choosing beam quality? Strahlenther Onkol (1999) 0.76

Hyperthermia in eccentrically located pelvic tumors: excessive heating of the perineal fat and normal tissue temperatures. Int J Radiat Oncol Biol Phys (1991) 0.76

[Radiotherapy of non-malignant diseases: principles and recommendations]. Rontgenpraxis (2000) 0.76

Blood flow and steady state temperatures in deep-seated tumors and normal tissues. Int J Radiat Oncol Biol Phys (1992) 0.76

Primary radiotherapy with or without chemotherapy in non-metastatic esophageal squamous cell carcinoma: a retrospective study. Dis Esophagus (2011) 0.75

Clinical, molecular- and cytogenetic analysis of a case of severe radio-sensitivity. Curr Genomics (2012) 0.75

[Is there an "primary lesion" in the pathogenesis of radiation-induced damage to the small intestine?]. Strahlenther Onkol (2001) 0.75

[Quality management and experiences with the "cancer center"]. Dtsch Med Wochenschr (2002) 0.75

Deep regional hyperthermia: comparison between the annular phased array and the sigma-60 applicator in the same patients. Int J Radiat Oncol Biol Phys (1993) 0.75

Report of a male patient with brain metastases from breast cancer. Breast (2003) 0.75

Sequential and/or concurrent hypofractionated radiotherapy and concurrent chemotherapy in neoadjuvant treatment of advanced adenocarcinoma of the pancreas. Outcome and patterns of failure. Hepatogastroenterology (2004) 0.75

[Stereotactic radiation therapy with a modified linear accelerator in patients with brain metastases]. Nervenarzt (2001) 0.75

Preoperative radiochemotherapy and radical surgery of advanced head and neck cancers--results of a prospective, multicenter DOSAK study. Recent Results Cancer Res (1994) 0.75

[Organizational prerequisites for multimodality therapy concepts]. Kongressbd Dtsch Ges Chir Kongr (2001) 0.75

[Late pelvic recurrence of rectal cancer]. Chirurg (1993) 0.75

Hyperthermia--its actual role in radiation oncology. Part II: Clinical fundamentals and results in superficial tumors. Strahlenther Onkol (1993) 0.75

[Indications for neoadjuvant therapy in rectal carcinoma]. Chirurg (2003) 0.75

[The value of dynamic MRT in the perfusion evaluation of pelvic tumors under hyperthermia]. Rofo (1993) 0.75